Zobrazeno 1 - 10
of 1 050
pro vyhledávání: '"uterine serous carcinoma"'
Autor:
Francis Hong Xin Yap, Yancey Wilson, Joanne Peverall, Benhur Amanuel, Ben Allanson, Sukeerat Ruba
Publikováno v:
Journal of Molecular Pathology, Vol 5, Iss 3, Pp 405-414 (2024)
Primary endometrial serous carcinoma, known for its aggressive nature and poor prognosis, shares similarities with breast and gastric cancers in terms of potential HER2 overexpression as a therapeutic target. Assessing HER expression is complicated b
Externí odkaz:
https://doaj.org/article/4655c893ad04415ebf49bebb78407a6c
Autor:
Katelyn Tondo-Steele, Kara J. Milliron, Jean H. Siedel, Shitanshu Uppal, Sofia D. Merajver, Karen McLean
Publikováno v:
Gynecologic Oncology Reports, Vol 55, Iss , Pp 101498- (2024)
An increase in the risk of developing uterine serous carcinoma (USC) has been observed among BRCA1 and BRCA2 germline pathogenic variant carriers in the published literature. However, routine germline genetic testing is not currently incorporated int
Externí odkaz:
https://doaj.org/article/11d9ba34d5b74130af7c5cd8e3b416cd
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Pure uterine serous carcinoma (p-USC) and mixed tumors with serous component (m-USC) are aggressive subtypes of endometrial cancer associated with high mortality rates. This retrospective study aimed to compare clinicopathologic f
Externí odkaz:
https://doaj.org/article/6b98c6f299cb4a2fb041dfbdcf5b23cd
Autor:
Wesley C. Burkett, Ziyi Zhao, Meredith A. Newton, Wenchuan Sun, Boer Deng, Angeles Alvarez Secord, Chunxiao Zhou, Victoria Bae-Jump
Publikováno v:
Annals of Medicine, Vol 55, Iss 1, Pp 603-614 (2023)
AbstractPurpose Uterine serous carcinoma (USC) exhibits worse survival rates compared to the endometrioid subtype, and there is currently no effective treatment options for recurrence of this disease after platinum-based chemotherapy. Activation of P
Externí odkaz:
https://doaj.org/article/ecb88b1b26b24a17813aa38f363d5220
Autor:
Gong Zhang, Fangfang Nie, Weinan Zhao, Pin Han, Jing Wen, Xiaoran Cheng, Weijia Wu, Qianwen Liu, Yi Sun, Yuanpei Wang, Yuchen Liu, Fang Ren
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Endometrial carcinoma (EC) is the second most common gynecological malignancy, and the differences between different pathological types are not entirely clear. Here, we retrospectively collected eligible EC patients to explore the
Externí odkaz:
https://doaj.org/article/007746a23b8b4407b449b4be53229f91
Autor:
Mehmet Unsal, Cigdem Kilic, Caner Cakir, Fatih Kilic, Burak Ersak, Sema Karakas, Nedim Tokgozoglu, Bulut Varli, Okan Oktar, Gunsu Kimyon Comert, Isa Aykut Ozdemir, Nurettin Boran, Tayfun Toptas, Isin Ureyen, Vakkas Korkmaz, Salih Taskin, Ozlem Moraloglu Tekin, Yaprak Ustun, Tolga Tasci, Firat Ortac, Taner Turan
Publikováno v:
Journal of Obstetrics and Gynaecology, Vol 43, Iss 1 (2023)
The aim of this study was to evaluate the prognostic factors for and determine the effect of neoadjuvant chemotherapy (NACT) on oncologic outcome in stage IVB pure serous endometrial carcinoma patients who received taxane and platinum. Forty-two pati
Externí odkaz:
https://doaj.org/article/649203dfaeb74bdfa6b5c6b2a3948fd9
Autor:
Isabel C. Lopez‐Mejia, Jordi Pijuan, Raúl Navaridas, Maria Santacana, Sònia Gatius, Ana Velasco, Gerard Castellà, Anaïs Panosa, Elisa Cabiscol, Miquel Pinyol, Laura Coll, Núria Bonifaci, Laura Plata Peña, August Vidal, Alberto Villanueva, Eloi Gari, David Llobet‐Navàs, Lluis Fajas, Xavier Matias‐Guiu, Andrée Yeramian
Publikováno v:
Molecular Oncology, Vol 17, Iss 1, Pp 98-118 (2023)
Uterine serous carcinoma (USC) is an aggressive form of endometrial cancer (EC), characterized by its high propensity for metastases. In fact, while endometrioid endometrial carcinoma (EEC), which accounts for 85% of EC, presents a good prognosis, US
Externí odkaz:
https://doaj.org/article/f663469d36c74406919fb1ffb516ab40
Autor:
Blair McNamara, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, Alessandro D. Santin
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp 101219- (2023)
Background: Treatment of uterine serous carcinoma (USC) is challenging; effective treatment options for metastatic and recurrent disease are needed. Case: A 68-year-old woman with recurrent, metastatic, USC overexpressing HER2/neu experienced durable
Externí odkaz:
https://doaj.org/article/65f35d1815de4ce1953b17e0506522e9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.